Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Featured News - Ofloxacin > Shanghai Hyundai Pharmaceutical's raw material drug operating income in 2020 is 4.788 billion yuan, an increase of 16.11% year-on-year
— Share —

Shanghai Hyundai Pharmaceutical's raw material drug operating income in 2020 is 4.788 billion yuan, an increase of 16.11% year-on-year

healthoo 2021-03-26
On March 26, Shanghai Hyundai Pharmaceutical announced its 2020 results. The raw materials part is as follows

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.